Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-14

Clinical Trial Update: Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes [Phase 4]

View source ↗

Summary

Phase 4 prospective study evaluated repository corticotropin for various nephrotic syndromes. Sponsored by the Arizona Kidney Disease and Hypertension Center, t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Repository Corticotropin (adrenocorticotropic hormone)

Snippet

Sponsor: Arizona Kidney Disease and Hypertension Center | Conditions: Nephrotic Syndromes | Phase 4 | Status: COMPLETED